PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland. mlodyga@op.pl\', \'Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland\', \'Department of Gastroenterology, Dietetics and Internal Medicine, Poznan University of Medical Sciences, Heliodor Święcicki University Hospital, Poznań, Poland\', \'Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznań, Poland\', \'Department of Gastroenterology, Medical University of Lodz, Łódź, Poland\', \'Diagnostic Laboratory, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland\', \'Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland\', \'Satellite Campus in Warsaw, University of Humanities and Economics in Lodz, Warsaw, Poland\', \'Collegium Medicum, Jan Kochanowski University, Kielce, Poland\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.20452/pamw.15796
?:doi
?:hasPublicationType
?:journal
  • Polish archives of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 33544564
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all